Eli Lilly Corp. buy Barclays PLC
Start price
31.10.24
/
50%
€771.40
Target price
31.10.25
€896.61
Performance (%)
-3.29%
End price
01.11.25
€746.00
Summary
This prediction ended on 01.11.25 with a price of €746.00. With a performance of -3.29%, the BUY prediction for Eli Lilly Corp. by Barclays_PLC closed slightly in the red. Barclays_PLC has a follow-up prediction for Eli Lilly Corp. where he still thinks Eli Lilly Corp. is a Buy. Dividends of €2.66 are taken into consideration when calculating the performance. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Eli Lilly Corp. | -0.391% | -0.391% | -0.825% |
| iShares Core DAX® | 1.232% | 1.501% | 11.288% |
| iShares Nasdaq 100 | 0.695% | -1.949% | 5.586% |
| iShares Nikkei 225® | 2.085% | 11.061% | 31.150% |
| iShares S&P 500 | 0.419% | 0.215% | 4.116% |
Comments by Barclays_PLC for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (NYSE: LLY) had its price target lowered by analysts at Barclays PLC from $1,025.00 to $975.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
In the thread Trading Eli Lilly Corp.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€849.00
21.02.26
21.02.26
€1,145.6
21.02.27
21.02.27
2.00%
26.02.26
26.02.26
Stopped prediction by Barclays_PLC for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€859.00
11.07.24
11.07.24
€941.16
11.07.25
11.07.25
-21.42%
12.07.25
12.07.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€676.00
07.02.24
07.02.24
€751.76
07.02.25
07.02.25
26.20%
08.02.25
08.02.25
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€580.50
23.01.24
23.01.24
€625.12
23.01.25
23.01.25
25.75%
24.01.25
24.01.25